Burger H R, Briner J, Spycher M A
Schweiz Med Wochenschr. 1979 Mar 24;109(12):423-31.
The development of severe proteinuria or nephrotic syndrome as an adverse reaction to gold therapy in rheumatoid arthritis is well known. Morphologic examination reveals membranous glomerulonephritis in almost all cases. Since the beginning of 1978 there has been a striking increase in the number of such cases seen at this institute. 5 patients aged from 17 to 65 years who had been treated with sodium aurothiomalate for rheumatoid arthritis developed severe proteinuria. In all cases only minimal glomerular changes were observable by light microscopy. Electron microscopy demonstrated multiple electrondense, subepithelial deposits which were confirmed by fluorescence microscopy. In all cases characteristic lysosomes ("aurosomes") were demonstrated in the cytoplasm, mainly of the epithelial glomerular cells. This unusual accumulation of almost identical cases coincides with the introduction of a new gold preparation, Na-aurothiomalate (Tauredon), containing 46% metallic gold.
类风湿关节炎患者接受金疗法治疗时出现严重蛋白尿或肾病综合征作为不良反应已为人熟知。形态学检查几乎在所有病例中均显示为膜性肾小球肾炎。自1978年初以来,该研究所所见的此类病例数量显著增加。5例年龄在17至65岁之间、曾接受硫代苹果酸金钠治疗类风湿关节炎的患者出现了严重蛋白尿。所有病例经光学显微镜观察仅可见轻微的肾小球改变。电子显微镜显示有多个电子致密的上皮下沉积物,荧光显微镜检查证实了这一点。所有病例在细胞质中,主要是肾小球上皮细胞中均显示出特征性的溶酶体(“金体”)。几乎相同病例的这种异常增多与一种新的金制剂硫代苹果酸金钠(Tauredon)的引入相吻合,该制剂含46%的金属金。